Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 1.000 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.514 | |
| 4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.513 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.478 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.477 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.477 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.472 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.472 | |
| 4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.470 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.468 | |
| 1jqh | ANP | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.466 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.465 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.464 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.464 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.463 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.461 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.461 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.460 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.458 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.457 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.456 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
| 4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.456 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.456 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.455 | |
| 4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.455 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.453 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
| 4ifc | ADP | Serine/threonine-protein kinase PRP4 homolog | 2.7.11.1 | 0.449 | |
| 3beg | ANP | SRSF protein kinase 1 | 2.7.11.1 | 0.448 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.446 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.445 | |
| 3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.444 | |
| 4xhg | ADP | Uncharacterized protein | / | 0.444 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.443 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
| 2hw1 | ANP | Ketohexokinase | / | 0.442 | |
| 2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 4icy | FAD | PgaE | / | 0.442 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.441 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 3llt | ANP | Protein serine/threonine kinase-1 | / | 0.440 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
| 3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 |